🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Fatuma Some

ORCID: 0000-0002-7127-3909

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 5 papers. Top paper: “Treatment outcomes of esophageal cancer in Eastern Africa: protocol of a multi-center, prospective, observational, open cohort study”.

Treatment outcomes of esophageal cancer in Eastern Africa: protocol of a multi-center, prospective, observational, open cohort study

BMC Cancer(2022)10.1186/s12885-021-09124-5

N/A

0.482DataRank · unranked

10 citations

Alita Mrema, Michael Mwachiro, Yona Ringo, Msiba Selekwa, Gift Mulima +39 more

Effectiveness of Double-Dose Dolutegravir in People Receiving Rifampin-based Tuberculosis Treatment: An Observational, Cohort Study of People With HIV From 6 Countries

Clinical Infectious Diseases(2024)10.1093/cid/ciae269

N/A

0.241DataRank · unranked

4 citations

Cissy Kityo, Michael D. Hughes, Caitlyn McCarthy, Carole L. Wallis, Mina C. Hosseinipour +28 more

Hepatocellular carcinoma: measures to improve the outlook in sub-Saharan Africa

The Lancet. Gastroenterology & hepatology(2022)10.1016/s2468-1253(22)00041-3

N/A

0DataRank · unranked

46 citations

Geoffrey Dusheiko, Eduard Jonas, Abdelmounem Abdo, Mary Afihene, Lina Cunha +18 more

Virological and drug-resistance outcomes for people living with HIV initiating or switching to tenofovir, lamivudine, and dolutegravir in six PEPFAR-supported countries: a prospective cohort study

The Lancet HIV(2025)10.1016/s2352-3018(25)00162-6

N/A

0DataRank · unranked

3 citations

Caitlyn McCarthy, Carole L. Wallis, Cissy Kityo, Michael D. Hughes, Catherine Godfrey +44 more

Virology Outcomes of Tenofovir-lamivudine-dolutegravir in Treatment-naïve and Virologically Suppressed Individuals Switching From an NNRTI-based Regimen: An Observational Analysis at 13 Sites

Open Forum Infectious Diseases(2025)10.1093/ofid/ofaf270

N/A

0DataRank · unranked

1 citations

Caitlyn McCarthy, Serena P. Koenig, Michael D Hughes, Carole L. Wallis, Isaac Tsikhutsu +41 more